Journal article
Phenylalanine-544 plays a key role in substrate and inhibitor binding by providing a hydrophobic packing point at the active site of insulin-regulated aminopeptidase
AL Albiston, V Pham, S Ye, L Ng, RA Lew, PE Thompson, JK Holien, CJ Morton, MW Parker, SY Chai
Molecular Pharmacology | Published : 2010
Abstract
Inhibitors of insulin-regulated aminopeptidase (IRAP) improve memory and are being developed as a novel treatment for memory loss. In this study, the binding of a class of these inhibitors to human IRAP was investigated using molecular docking and site-directed mutagenesis. Four benzopyran-based IRAP inhibitors with different affinities were docked into a homology model of the catalytic site of IRAP. Two 4-pyridinyl derivatives orient with the benzopyran oxygen interacting with the Zn2+ ion and a direct parallel ring-stack interaction between the benzopyran rings and Phe544. In contrast, the two 4-quinolinyl derivatives orient in a different manner, interacting with the Zn2+ ion via the quin..
View full abstractGrants
Awarded by National Health and Medical Research Council (NHMRC)
Funding Acknowledgements
This research was supported by the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation; the Alzheimer's Drug Discovery Foundation; a Neurosciences Victoria/Victorian State Government Science, Technology, and Innovation Grant; the National Health and Medical Research Council (NHMRC) [Development Grants 454714 and 520695]; an NHMRC Peter Doherty fellowship (to V.P.); an Australian Research Council Federation Fellowship (to M.W.P.); an NHMRC Honorary Fellowship (to M.W.P.); and an NHMRC Senior Research Fellowship (to S.Y.C.).